Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

China flag China · Delayed Price · Currency is CNY
5.94
+0.10 (1.71%)
Jun 12, 2026, 3:04 PM CST
Market Cap7.42B -2.3%
Revenue (ttm)1.48B -2.5%
Net Income322.88M -21.8%
EPS0.26 -20.4%
Shares Out 1.25B
PE Ratio22.95
Forward PEn/a
Dividend0.15 (2.53%)
Ex-Dividend DateMay 29, 2026
Volume11,399,116
Open5.95
Previous Close5.84
Day's Range5.79 - 5.95
52-Week Range5.77 - 12.75
Beta0.04
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHE:002550

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China. [Read more]

Sector Healthcare
Founded 1971
Employees 1,038
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002550
Full Company Profile

Financial Performance

In 2025, SHE:002550's revenue was 1.57 billion, an increase of 2.95% compared to the previous year's 1.53 billion. Earnings were 398.80 million, an increase of 12.01%.

Financial Statements